NCT06804057View on ClinicalTrials.gov

CorEvitas Systemic Lupus Erythematosus (SLE) Drug Safety and Effectiveness Registry

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

September 26, 2024

Primary Completion Date

December 31, 2099

Study Completion Date

December 31, 2099

Conditions
Systemic Lupus Erythematosus
Interventions
OTHER

Blood Collection

Blood will be collected for the subjects who are willing to participate in the optional biorepository

Trial Locations (1)

02451

RECRUITING

CorEvitas, Waltham

Sponsors

Lead Sponsor

CorEvitas
All Listed Sponsors
lead

CorEvitas

NETWORK

NCT06804057 - CorEvitas Systemic Lupus Erythematosus (SLE) Drug Safety and Effectiveness Registry | Biotech Hunter | Biotech Hunter